Recovery from Severe Hyperthermia (45°C) and Rhabdomyolysis Induced by Methamphetamine Body-Stuffing by Suchard, Jeffrey R.
Volume VIII, n o . 3  :  August 2007                                                 93                                      Western Journal of Emergency Medicine
Jeffrey R. Suchard, MD
Ca s e  re p o r t
Recovery from Severe Hyperthermia (45°C) and 
Rhabdomyolysis Induced by Methamphetamine 
Body-Stuffing
Department of Emergency Medicine, University of California, Irvine School of Medicine
Submission history: Submitted May 8, 2007; Accepted June 12, 2007. 
Reprints available through open access at www.westjem.org
[WestJEM. 2007;8:93-95.]
INTRODUCTION
   The acute toxic effects of sympathomimetic stimulant 
drugs include hypertensive crisis, coronary and cerebral 
vasospasm, cardiac dysrthythmias, seizures, hyperthermia, 
rhabdomyolysis, and metabolic derangements such as 
hyperglycemia, metabolic acidosis, and either hyper- or 
hypokalemia.1 This report presents a case of complete 
recovery from severe hyperthermia with a temperature at 45°C 
(113°F) and rhabdomyolysis resulting from methamphetamine 
body-stuffing	and	physical	exertion.	The	patient’s	initial	




   A 23-year-old man was a restrained driver involved in 
a minor motor vehicle collision with a police cruiser, and 
suffered no apparent injuries. Fearing that he would be 
arrested for possession of illicit drugs, the driver ingested what 
he later estimated to be 100 dose-units of methamphetamine 
(≥1	gram)	he	had	been	selling.	He	then	fled	the	scene	on	foot.	
A chase ensued, and he was apprehended by police while 
running around the roof of one building and attempting to 
jump to another roof. The ambient temperature at that time 
was approximately 22°C (75°F), with a relative humidity of 
39%, giving a heat index of 25°C (77°F). The police placed 
restraints on their suspect’s lower extremities and then 
summoned paramedic-level emergency medical technicians 
(EMTs) to transport him for medical evaluation.
   Upon their arrival, EMTs found the patient combative and 
screaming with a repetitive speech pattern. Vital signs in the 
field	were:	pulse	at	~200/min	(sinus	tachycardia	on	cardiac	
monitor), respirations at 40/min (rapid and shallow), and an 
oxygen saturation of 98% on ambient air. Blood pressure 
could not be recorded due to the patient’s agitation, and body 
temperature was not measured. Physical examination by the 
EMTs was notable for warm, diaphoretic skin, mydriasis, and 
some dried blood around the lips, but no other gross signs 
of trauma. Intravenous (IV) access could not be established 
due to the patient’s agitation, and he was transported within 4 
minutes to the nearest hospital emergency department (ED).
   Upon arrival to the ED the patient was agitated, combative, 
and both physically and verbally threatening to the staff. 
He was placed in four-point leather restraints and rapidly 
evaluated. Vital signs were: pulse at 164/min, respirations at 
30/min, blood pressure at 152/70 mmHg, and temperature 
at 43.6°C (110.4°F) orally. Only one oral temperature 
measurement was made before resuscitative measures began. 
IV access was established and hydration initiated with 0.9% 
saline in one-liter boluses. To control the patient’s extreme 
agitation and facilitate treatment, he was endotracheally 
intubated with rapid sequence induction using 10 mg 
IV lorazepam and 10 mg IV vecuronium. A core body 
temperature was then measured at 45.0°C (113°F) with a 
rectal probe thermometer, which was used intermittently 
during the ED course. Additional cooling measures employed 
were the application of ice packs to the groin and axillae and 
a cooling blanket. A Foley catheter was inserted, with return 
of	~200cc	dark,	red	urine.	Physical	examination	revealed	skin	
abrasions to the lower right anterior chest wall, bilateral knees 
and knuckles, apparently sustained during the chase, but no 
other evidence of trauma. An electrocardiogram revealed a 
wide-complex sinus tachycardia at a rate of 162/min with a 
QRS duration of 122 msec.
   Initial laboratory results were: arterial pH at 7.38, pCO2 
at 31.0 mmHg, pO2 at 551 mmHg, serum creatinine 
phosphokinase (CPK) at 2083 IU/L, CPK-MB at 10.9 IU/L, 
white blood cell count at 11.1 k/mm3, hematocrit at 41.4%, 
and platelet count at 274 k/mm3. Computed tomography of 
the head was within normal limits. Urine drug screening by 
enzyme-multiplied immunoassay technique (EMIT) was 
positive for amphetamines and cannabinoids only.Western Journal of Emergency Medicine                                       94                                               Volume VIII, n o . 3  :  August 2007 
   One hundred minutes after ED arrival, the patient’s core 
temperature had decreased to 38.1°C (100.6°F). He was given 
a	total	of	6300cc	IV	fluids	prior	to	transfer	via	helicopter	to	
the regional toxicology referral center; urine output in this 
time was 1800cc over three hours.
   The patient arrived in the intensive care unit (ICU) 3.5 hrs 
after initiation of treatment. Vital signs on ICU arrival were: 
temperature at 36.4°C (97.6°F), pulse at 128/min, and blood 
pressure at144/56 mmHg. Laboratory investigation showed: 
hematocrit at 37.9%, platelet count at 105 k/mm3, prothrombin 
time	at	14.3	sec,	fibrinogen	at	258	mg/dL,	fibrin	split	products	
at <5 mg/dL, sodium at 141 mEq/L, potassium at 3.8 mEq/L, 
chloride at 109 mEq/L, bicarbonate at 21 mEq/L, blood urea 
nitrogen (BUN) at 17 mg/dL, creatinine at 1.1 mg/dL, glucose 
at 112 mg/dL, calcium at 5.5 mEq/L, magnesium at 2.3 
mEq/L, phosphate at 2.2 mEq/L, CPK at 12,173 IU/L, CPK-
MB at 110 IU/L, with no detectable acetaminophen, salicylate, 
or ethanol. Comprehensive urine drug screening by EMIT, 
thin-layer chromatography (TLC), and gas chromatography-
mass	spectroscopy	(GC-MS)	confirmed	the	presence	of	
methamphetamine, amphetamine, caffeine, and cannabinoids 
only. No cocaine or benzoylecgonine (the primary cocaine 
metabolite) were detected.
   The patient was treated with supplemental IV calcium, and 
was given activated charcoal via nasogastric tube. Aggressive 
IV	hydration	with	bicarbonate-containing	fluids	(D5W	with	
150 mEq NaHCO3 and 40 mEq KCl per liter infused at 
250 cc/hr) to alkalinize the urine was continued. Including 
the initial boluses with normal saline, the patient received 
9200cc	total	IV	fluids	within	the	first	12	hours	of	treatment.	A	
urinalysis performed 11 hours after ED arrival showed: pH at 
9.0,	specific	gravity	at	1.015,	3+	protein,	3+	blood,	and	20-30	
red blood cells/hpf.
   The patient remained comatose for 26 hours after intubation, 
but was successfully extubated on the second hospital day. 
The patient exhibited tachycardia, agitation, confusion, 
picking movements of the hands, and paranoid delusional 
thinking which slowly resolved over the following two days. 
Serial laboratory measurements showed a rapid rise in serum 
CPK, peaking at 119,901 IU/L on the third hospital day. The 
patient’s peak serum creatinine was 1.1 mg/dL (at the time 
of ICU admission), and the BUN peaked at 18 mg/dL a few 
hours later. The patient never developed clinical evidence 
for a compartment syndrome as the basis for his notable 
rhabdomyolysis, nor did he experience a drop in urine output. 
The patient was discharged home on hospital day 5, with 
serum CPK at 39,006 IU/L, BUN at 6 mg/dL, and creatinine 
at 0.7 mg/dL. The patient and his wife agreed that his mental 
status had returned to baseline, with no detectable neurologic 
deficits.	The	patient	was	advised	to	return	immediately	for	
decreased urinary output, weakness, or other problems.
DISCUSSION
   Hyperthermia is well recognized as a cause of major 
morbidity and mortality.2 Hyperthermia may be caused 
by environmental exposure, infection, central thermic 
dysregulation, and/or by ingestion of various drugs. During 
the period from 1999-2003, the Centers for Disease Control 
and Prevention reported 3,442 heat-related deaths in the 
United States, 2,239 of which were due to exposure to 
excessive environmental heat, but without documentation of 
hyperthermia in the victims. Of the remaining 1,203 deaths 
associated with hyperthermia, 345 (29%) were associated 
with “external causes (e.g., unintentional poisonings)”.3 The 
exact pathophysiologic cause of death from hyperthermia is 
not known, but is probably multifactorial. Autopsy results 
have shown tissue injury to the myocardium, kidneys, central 
nervous system, liver, and skeletal muscle. Tissue injury is 
often worse in cases of exertional heatstroke, compared to 
“classic” heatstroke due to excessive environmental exposure.4
   In their review of 250 cases of drug-related heatstroke, 
Clark and Lipton found that nearly half of the patients had 
a maximal recorded body temperature of 40-41°C and their 
survival rate was 69%.5 About one-quarter had a temperature 
of 41.1-42.1°C, with 53% survival; the remaining victims 
with temperatures >42.1°C had a survival rate of only 30%.5 
The highest reported core body temperature in a patient 
who	survived	without	permanent	residual	deficits	was	
46.5°C (115.7°F).6 This 52-year-old patient suffered from 
environmental heatstroke, possibly exacerbated by ethanol 
consumption. In fact, this patient’s peak temperature was 
likely higher, as an accurate measurement was not made until 
25 minutes after initiating active cooling measures.
   A case of even more extreme hyperthermia from 
sympathomimetic drug use has been reported, but lacked 
positive	laboratory	test	results	to	confirm	the	drug	exposure.	
Roberts et al7 reported the case of a patient with a rectal 
temperature of 45.6°C (114°F) after IV injection of a 
substance thought to be cocaine; however, no cocaine or 
amphetamines were detected in either blood or urine.
   The extreme hyperthermia (45°C; 113°F) seen in the patient 
presented here, therefore, represents the highest reported 
core	body	temperature	in	a	case	with	laboratory	confirmation	
of psychostimulant drug exposure. Both the EMIT and GC-
MS	methodologies	confirmed	the	presence	of	amphetamines	
and the absence of cocaine. The number of compounds 
that could be detected by GC-MS in the referral center’s 
laboratory exceeded 1500, and included most anticholinergic 
drugs (such as atropine, scopolamine, diphenhydramine, 
benztropine, cyclic antidepressants, and antipsychotics) 
which might produce a similar clinical picture in overdose. 
These drug detection tests are qualitative, not quantitative, 
so they only prove drug exposure but not overdose. Serum 
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levels of methamphetamine and/or amphetamine would 
have	been	the	most	ideal	laboratory	confirmation	of	acute	
overdose, but these were not obtained during the period of the 
patient’s acute, severe intoxication. Nevertheless, the patient’s 
history and clinical course were consistent with acute, severe 
sympathomimetic toxicity.
   Drug-related and combination drug/environmental 
heatstroke victims commonly develop multisystem organ 
failure, characterized by rhabdomyolysis, acute renal failure, 
and disseminated intravascular coagulation (DIC). The patient 
presented here never developed renal failure or DIC, despite 
extreme hyperthermia and severe rhabdomyolysis. Factors 
that may have affected outcome in this case include aggressive 
initial IV hydration, the relatively short duration of extreme 
hyperthermia, rapid employment of multiple cooling measures 
(including neuromuscular blockade), the patient’s baseline 
good health, and other supportive care measures. Drug-related 
heatstroke patients may require unusually vigorous initial IV 
hydration to correct intravascular volume depletion and to 
ensure	adequate	renal	blood	flow	and	urine	output,	guarding	
against heme pigment-induced nephropathy.
CONClUSION
  Severe hyperthermia may occur from the combination 
of	physical	exertion	and	methamphetamine	body-stuffing.	
Aggressive cooling measures, intravenous hydration, and 
urinary alkalinization resulted in complete recovery, despite 
rhabdomyolysis and prolonged sympathomimetic toxicity.
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